Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma

DSpace Repository

Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma

Author: Gaissler, Andrea; Bochem, Jonas; Spreuer, Janine; Ottmann, Shannon; Martens, Alexander; Amaral, Teresa; Wagner, Nikolaus Benjamin; Claassen, Manfred; Meier, Friedegund; Terheyden, Patrick; Garbe, Claus; Eigentler, Thomas; Weide, Benjamin; Pawelec, Graham; Wistuba-Hamprecht, Kilian
Tübinger Autor(en):
Gaißler, Andrea
Bochem, Jonas
Spreuer, Janine
Ottmann, Shannon
Martens, Alexander
Amaral, Teresa
Wagner, Nikolaus B.
Claassen, Manfred
Garbe, Claus
Weide, Benjamin
Pawelec, Graham
Wistuba-Hamprecht, Kilian
Published in: Journal For Immunotherapy of Cancer (2023), Bd. 11, H. 6
Verlagsangabe: London : Bmj Publishing Group
Language: English
Full text: http://dx.doi.org/10.1136/jitc-2023-006802
ISSN: 2051-1426
DDC Classifikation: 610 - Medicine and health
570 - Life sciences; biology
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)